Company Filing History:
1 out of 145 
1 out of 1,311 
Years Active: 1999
Title: The Innovations of Robert Tolan
Introduction
Robert Tolan is an accomplished inventor based in Indianapolis, IN (US). He is known for his significant contributions to the field of biotechnology, particularly in the study of membrane proteins and peptides related to Haemophilus influenzae type b. His work has implications for vaccine development and disease prevention.
Latest Patents
Robert Tolan holds a patent for "Membrane proteins and peptides of Haemophilus influenzae type B." This patent discloses the nucleotide sequence of the P2 gene and the derived amino acid sequence of the P2 protein. The methods used to determine these sequences are also detailed. Additionally, the patent outlines the cloning and expression methods for the P2 gene, along with a purification protocol for both the gene and protein. The synthesis of peptides corresponding to the N-terminal and C-terminal ends of the P2 protein is also included. Importantly, the patent discusses the use of the P2 protein as a protective agent against diseases caused by Haemophilus influenzae type b, as well as its potential as a carrier for conjugation with oligosaccharides to create an effective vaccine. Furthermore, the use of P2 peptide-conjugates as immunizing agents is disclosed.
Career Highlights
Throughout his career, Robert Tolan has worked with notable organizations, including Connaught Laboratories Limited and Washington University. His expertise in biotechnology has allowed him to make significant advancements in the field.
Collaborations
Robert Tolan has collaborated with esteemed colleagues such as Robert S. Munson, Jr. and Pele Chong. These partnerships have contributed to the success of his research and innovations.
Conclusion
Robert Tolan's work in the field of biotechnology, particularly his patent related to Haemophilus influenzae type b, showcases his innovative spirit and dedication to advancing medical science. His contributions have the potential to impact vaccine development and public health significantly.